58 related articles for article (PubMed ID: 15203286)
1. Delayed-late activation of a myeloid defensin minimal promoter by retinoids and inflammatory mediators.
Wang N; Su Q; Boeckh-Herwig S; Yaneva M; Tempst P
Leuk Res; 2004 Aug; 28(8):879-89. PubMed ID: 15203286
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells.
Turner EC; Kinsella BT
J Mol Biol; 2009 Feb; 386(3):579-97. PubMed ID: 19118563
[TBL] [Abstract][Full Text] [Related]
3. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
4. Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation.
Weigelt K; Ernst W; Walczak Y; Ebert S; Loenhardt T; Klug M; Rehli M; Weber BH; Langmann T
J Leukoc Biol; 2007 Dec; 82(6):1564-74. PubMed ID: 17827340
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
6. PU.1 and a TTTAAA element in the myeloid defensin-1 promoter create an operational TATA box that can impose cell specificity onto TFIID function.
Yaneva M; Kippenberger S; Wang N; Su Q; McGarvey M; Nazarian A; Lacomis L; Erdjument-Bromage H; Tempst P
J Immunol; 2006 Jun; 176(11):6906-17. PubMed ID: 16709851
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of the SOX3 gene expression by retinoic acid: characterization of the novel promoter-response element and the retinoid receptors involved.
Nikcević G; Savić T; Kovacević-Grujicić N; Stevanović M
J Neurochem; 2008 Dec; 107(5):1206-15. PubMed ID: 18786169
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the promoter region of the human PARG gene and its response to PU.1 during differentiation of HL-60 cells.
Uchiumi F; Sakakibara G; Sato J; Tanuma S
Genes Cells; 2008 Dec; 13(12):1229-47. PubMed ID: 19076642
[TBL] [Abstract][Full Text] [Related]
9. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
[TBL] [Abstract][Full Text] [Related]
10. Involvement of PU.1 in the transcriptional regulation of TNF-alpha.
Fukai T; Nishiyama C; Kanada S; Nakano N; Hara M; Tokura T; Ikeda S; Ogawa H; Okumura K
Biochem Biophys Res Commun; 2009 Oct; 388(1):102-6. PubMed ID: 19646961
[TBL] [Abstract][Full Text] [Related]
11. In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10).
McCahill A; Campbell L; McSorley T; Sood A; Lynch MJ; Li X; Yan C; Baillie GS; Houslay MD
Cell Signal; 2008 Nov; 20(11):2071-83. PubMed ID: 18721873
[TBL] [Abstract][Full Text] [Related]
12. Intracellular HMGB1 transactivates the human IL1B gene promoter through association with an Ets transcription factor PU.1.
Mouri F; Tsukada J; Mizobe T; Higashi T; Yoshida Y; Minami Y; Izumi H; Kominato Y; Kohno K; Tanaka Y
Eur J Haematol; 2008 Jan; 80(1):10-9. PubMed ID: 18173740
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the promoter of 1A6/DRIM, a novel cancer-related gene and identification of its transcriptional activator.
Xing X; Du X; Lu Z; Ning T; Su X; Ke Y
Gene; 2005 Jan; 344():161-9. PubMed ID: 15656982
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the preprotachykinin-I gene promoter through a protein kinase A-dependent, cyclic AMP response element-binding protein-independent mechanism.
Calin-Jageman IE; Wang J; Bannon MJ
J Neurochem; 2006 Apr; 97(1):255-64. PubMed ID: 16515544
[TBL] [Abstract][Full Text] [Related]
15. Regulation of GTP cyclohydrolase I gene transcription by basic region leucine zipper transcription factors.
Al Sarraj J; Vinson C; Han J; Thiel G
J Cell Biochem; 2005 Dec; 96(5):1003-20. PubMed ID: 16149046
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells.
Stearns ME; Kim G; Garcia F; Wang M
Mol Cancer Res; 2004 Jul; 2(7):403-16. PubMed ID: 15280448
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of human Oct4 by steroidogenic factor-1.
Yang HM; Do HJ; Kim DK; Park JK; Chang WK; Chung HM; Choi SY; Kim JH
J Cell Biochem; 2007 Aug; 101(5):1198-209. PubMed ID: 17226773
[TBL] [Abstract][Full Text] [Related]
18. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1.
Rosenbauer F; Owens BM; Yu L; Tumang JR; Steidl U; Kutok JL; Clayton LK; Wagner K; Scheller M; Iwasaki H; Liu C; Hackanson B; Akashi K; Leutz A; Rothstein TL; Plass C; Tenen DG
Nat Genet; 2006 Jan; 38(1):27-37. PubMed ID: 16311598
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide suppresses RANK gene expression in macrophages by down-regulating PU.1 and MITF.
Ishii J; Kitazawa R; Mori K; McHugh KP; Morii E; Kondo T; Kitazawa S
J Cell Biochem; 2008 Oct; 105(3):896-904. PubMed ID: 18759249
[TBL] [Abstract][Full Text] [Related]
20. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.
Zelko IN; Folz RJ
Free Radic Biol Med; 2004 Oct; 37(8):1256-71. PubMed ID: 15451065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
